Vivo Bio Tech Ltd Intrinsic Value
VIVOBIOT · Healthcare · Current price ₹23.48
Is Vivo Bio Tech Ltd undervalued?
DocStoX estimates the fair value of Vivo Bio Tech Ltd at ₹45 per share, versus the current market price of ₹23. That puts the stock about +93.1% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹40), Relative P/E (₹59), Graham floor (₹40). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹39 (bear) to ₹45 (base) to ₹59 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹23 versus an intrinsic value of ₹45, Vivo Bio Tech Ltd currently offers +93.1% of margin.
More on Vivo Bio Tech Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.